Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LDOC1L | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-06 |
mRNA | ZNF329 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
mRNA | SBK1 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-06 |
mRNA | ZNF814 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-06 |
mRNA | FAM159B | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
mRNA | PMAIP1 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-06 |
mRNA | YLPM1 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-06 |
mRNA | SORCS3 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-06 |
mRNA | NUP62 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-06 |
mRNA | MBD3 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |